We aim to make your pharma-education as easy as possible. Therefore, we have included some useful resources to help you understand various aspects of the pharmaceutical industry. If there is any other area you feel should be covered, please contact us as info@pharmaware.co.uk and let us know.

Within PharmAware there is a library of resources held by various members. Click on our link to see what's in the library. If you have any resource you think may be of interest, please let us know and we will add it to the library.
 

External Resource

1. The impact of healthcare professional interaction with pharmaceutical industry          What do medical students think about pharmaceutical promotion? BMA guidance for medical students Research Transparency: Industry attack on academics, BMJ 2009;338:b736. ABPI guidance notes on Joint Working between Pharmaceutical Companies and the NHS and others for the benefit of patients, March 2009 Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement  Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement, BMJ, 31/5/03 Expensive lunch student BMJ, September 2003 Characteristics of GPs who frequently see Drug Industry Reps, 31/5/03 WHO Department of Essential Drugs and Health Action International Europe (HAI-E) report on pharmaceutical promotion "The Influence of the Pharmaceutical Industry". Report of the House of Commons Health Committee. 5 April 2005 Medical journals and pharmaceutical companies: uneasy bedfellows, 31/5/03 Royal College of Physicians: Innovating for Health. (Full report can be dowloaded if member of RCP)   2. Post-Graduate Education Drug company sponsorship of education could be replaced at a fraction of its cost BMJ, 31/5/03 Rethinking continuing medical education, BMJ 2008;337:973   3. Direct-to-consumer advertising Direct to consumer advertising, BMJ 2005;330:5-6  Gellad ZF. Lyles KW. Direct-to-consumer advertising of pharmaceuticals. American Journal of Medicine. 120(6):475-80, 2007.   4. Disease Mongering The making of a disease: female sexual dysfunction BMJ, 4/1/03 The Fight against Disease Mongering: Generating Knowledge for Action PLOS Medicine, April 2006   5. International Research and Development/Neglected Diseases Stoking the antibiotic pipeline, BMJ 2010; 340: c2115 Ethical concerns in clinical trials in India: an investigation, Centre for Studies in Ethics and Rights, Feb 2009 Murder by fake Drugs, BMJ 6/4/2 A New Trade Framework for global healthcare R&D, PLoS Biology, Feb 2004      Access to Medicines, BMA Position paper The impact of open access upon public health, WHO bulletin - Volume 84, Number 5, May 2006, 337-424 Bulletin interview: Do patents work for public health? - Interview with Carlos Correa; CIPIH report: main recommendations; Recent news from WHO, WHO bulletin - Volume 84, Number 5, May 2006, 337-424 TRIPS and priority vaccines, WHO bulletin - Volume 84, Number 5, May 2006, 337-424 Essential medicines and human rights, WHO bulletin - Volume 84, Number 5, May 2006, 337-424 Antiretroviral pricing in Global Fund programmes, WHO bulletin - Volume 84, Number 5, May 2006, 337-424 World Trade Organisation, 2003. Fact Sheet: TRIPS and pharmaceutical.  Selection and Rational Use of Medicines, WHO.   The "Secret" Report - The report of the invesigation committee on the clinical trial of Trovan by Pfizer, Kano, 1996  Fatal Imbalance, The Crisis in Research and Development for Drugs for Neglected Diseases, MSF, September 2001 6. UK research and development Tightening Grip of Big Pharma, The Lancet, 14/4/01 How can research ethics committees protect patients better? BMJ 31/5/03 All change for funding of medical research in the UK, BMJ, 29/4/06 Reporting bias in medical research - a narrative review 7. Regulations How to dance with porcupines: rules and guidelines on doctors' relations with drug companies BMJ 31/5/03 GMC Good Medical Practice, Conflict of Interest, Paragraph 74-5 Pharmaceutical Pricing Regulation Scheme, Department of Health, UK ABPI Code of Practice Yale policy University of Pennsylvania policy Stanford policy 8. Evidence-based medicine Evidence based medicine: what it is and what it isn't, BMJ 1996;312:71-7 Understanding Statistical Terms 1, DTB Understanding Statistical Terms 2, DTB An Introduction to critical appraisal, Keel University SIGN Checklists

 

Books "The Truth About the Drug Companies" by Marcia Angell. New York: Random House, 2004. Revised and updated in 2005.  "Big Pharma" by Jacky Law. Constable, 2006. Strong Medicines by Arthur Hailey Bitter Pills, Oxfam Roche versus Adams "On the Take: How Medicine's Complicity with Big Business Can Endanger Your Health," by Jerome P. Kassirer. Oxford University Press, 2005